Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

BACKGROUND & AIMS The influence of HFE gene mutations and liver iron overload on hepatocellular carcinoma (HCC) occurrence in patients with cirrhosis is subjected to controversial results. The aim of this work was to clarify this influence in a large cohort of prospectively followed-up cirrhotic patients classified according to the cause of their liver disease. METHODS Three hundred one consecutive cirrhotic patients (162 alcoholics and 139 HCV-infected patients) were included at time of diagnosis of cirrhosis and followed-up. Liver iron overload on initial biopsy according to modified Deugnier's score and C282Y/H63D HFE gene mutations were assessed. RESULTS In patients with alcoholic cirrhosis (mean iron score, 2.0 +/- 3.0; mean time of follow-up, 66.1 +/- 45.1 months), 40 (24.6%) developed HCC. Thirteen (8.02%) were heterozygotes for C282Y HFE gene mutation and had higher hepatic iron scores (3.6 +/- 3.8 vs 1.9 +/- 2.8, respectively, P = .05). In univariate analysis, liver iron overload as a continuous variable (HR, 1.23 [1.13-1.34], P < .001) or in binary coding with an optimal threshold of iron score >/=2.0 (HR, 4.1 [2.1-7.3], P < .0001) and C282Y mutation carriage (HR, 2.7 [1.2-6.3], P = .01) were risk factors for HCC. In multivariate analysis, liver iron and C282Y mutation carriage remained independent risk factors for HCC. In patients with HCV-related cirrhosis (C282Y mutation carriage, 17 [12.23%]; mean liver iron score, 0.9 +/- 1.9; mean time of follow-up, 85.5 +/- 42.1 months; HCC, 63 [45.32%] patients), C282Y mutation carriage and liver iron were not associated with HCC occurrence. CONCLUSIONS Liver iron overload and C282Y mutation are associated with a higher risk of HCC in patients with alcoholic but not HCV-related cirrhosis.

[1]  F. Azzaroli,et al.  Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. , 2006, World journal of gastroenterology.

[2]  M. Ziol,et al.  Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. , 2006, Cancer research.

[3]  Y. Kohgo,et al.  Iron accumulation in alcoholic liver diseases. , 2005, Alcoholism, clinical and experimental research.

[4]  M. Ziol,et al.  Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  K. Kowdley Iron, hemochromatosis, and hepatocellular carcinoma. , 2004, Gastroenterology.

[6]  M. Colombo,et al.  Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. , 2004, Gastroenterology.

[7]  Josep Fuster,et al.  The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  N. Ganne-Carrié,et al.  Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis , 2003, Gut.

[9]  C. Hellerbrand,et al.  HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Y. Deugnier Iron and liver cancer. , 2003, Alcohol.

[11]  M. Bronner,et al.  Hepatitis C, iron status, and disease severity: relationship with HFE mutations. , 2003, Gastroenterology.

[12]  C. Datz,et al.  Mutations of the HFE gene in patients with hepatocellular carcinoma. , 2003 .

[13]  D. Swinkels,et al.  Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes) , 2002, Human mutation.

[14]  L. Rodrigo,et al.  HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. , 2002 .

[15]  R. N. Macsween,et al.  The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C , 2002, Gut.

[16]  Y. Deugnier,et al.  Iron and hepatocellular carcinoma , 2001, Journal of gastroenterology and hepatology.

[17]  J. Bruix,et al.  Early diagnosis and treatment of hepatocellular carcinoma. , 2000, Bailliere's best practice & research. Clinical gastroenterology.

[18]  P. Schirmacher,et al.  Heterozygosity for the hemochromatosis gene in liver diseases--prevalence and effects on liver histology. , 2000, Liver.

[19]  C. Avellini,et al.  Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients , 2000, Cancer.

[20]  V. de Lédinghen,et al.  Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. , 2000, Journal of hepatology.

[21]  M. Ziol,et al.  Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study , 2000, Gut.

[22]  J. Pawlotsky,et al.  Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. , 1999, Journal of hepatology.

[23]  G. Mancia,et al.  Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations , 1998, Hepatology.

[24]  P. Brissot,et al.  Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. , 1997, Gut.

[25]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[26]  F. J. Farrell,et al.  Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  B. Cesana,et al.  Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis , 1992, Hepatology.

[28]  M. Kew Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: Occurrence in noncirrhotic patients , 1990 .

[29]  C. Datz,et al.  The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. , 1999, Gastroenterology.